18 noviembre 2014
A common malaria drug could have a significant impact on colorectal cancer providing a cheap adjunct to current expensive chemotherapy, medical experts say. Colorectal cancer (CRC) makes up about 10 percent of the annual 746,000 global cancer cases in men and 614,000 cases in women.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/9-x0bV3VdX0/141118091609.htm
